Autochthonous case of dengue in France, October 2013

Marchand, Elodie; Prat, Christine; Jeannin, Charles; Lafont, Emmanuel; Bergmann, Thobias; Flusin, Olivier; Rizzi, J; Roux, Nikki; Busso, V; Deniau, J.; Noël, Harold; Vaillant, V.; Leparc-Goffart, Isabelle; Six, C.; Paty, Marie-Claire

doi:10.2807/1560-7917.es2013.18.50.20661

Cited by 147 publications

(101 citation statements)

References 61 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…No severe clinical variants or deaths were reported [102,104]. In addition, one autochthonous case was reported in southern France in October 2013 [105]. While Aedes aegypti is re-emerging in Europe, Aedes albopictus is emerging [106,107] and an overall increase in Dengue risk is predicted, with the greatest increase expected in coastal areas of southern Europe [103]; see Table 7.…”

Section: Climate-sensitive Infectious Diseasesmentioning

confidence: 99%

The Health Effects of Climate Change in the WHO European Region

Wolf

Lyne

Martínez

et al. 2015

Climate

View full text Add to dashboard Cite

Abstract:The evidence of observed health effects as well as projections of future health risks from climate variability and climate change is growing. This article summarizes new knowledge on these health risks generated since the IPCC fourth assessment report (AR4) was published in 2007, with a specific focus on the 53 countries comprising the WHO European Region. Many studies on the effects of weather, climate variability, and climate change on health in the European Region have been published since 2007, increasing the level of certainty with regard to already known health threats. Exposures to temperature extremes, floods, storms, and wildfires have effects on cardiovascular and respiratory health. Climate-and weather-related health risks from worsening food and water safety and security, poor air quality, and ultraviolet radiation exposure as well as increasing allergic diseases, vector-and rodent-borne diseases, and other climate-sensitive health outcomes also warrant attention and policy action to protect human health.

show abstract

Section: Climate-sensitive Infectious Diseasesmentioning

confidence: 99%

The Health Effects of Climate Change in the WHO European Region

Wolf

Lyne

Martínez

et al. 2015

Climate

View full text Add to dashboard Cite

show abstract

“…Ae. albopictus was first detected in France in 2004 (101); it is now well established in the southern part of the country, where it was responsible for local transmission of dengue (102,218) and chikungunya (219). Ae.…”

Section: Imported Cases Of Zika Fever and Risk Of Dissemination In Armentioning

confidence: 99%

Zika Virus

2016

View full text Add to dashboard Cite

SUMMARYZika virus (ZIKV) is an arthropod-borne virus (arbovirus) in the genusFlavivirusand the familyFlaviviridae. ZIKV was first isolated from a nonhuman primate in 1947 and from mosquitoes in 1948 in Africa, and ZIKV infections in humans were sporadic for half a century before emerging in the Pacific and the Americas. ZIKV is usually transmitted by the bite of infected mosquitoes. The clinical presentation of Zika fever is nonspecific and can be misdiagnosed as other infectious diseases, especially those due to arboviruses such as dengue and chikungunya. ZIKV infection was associated with only mild illness prior to the large French Polynesian outbreak in 2013 and 2014, when severe neurological complications were reported, and the emergence in Brazil of a dramatic increase in severe congenital malformations (microcephaly) suspected to be associated with ZIKV. Laboratory diagnosis of Zika fever relies on virus isolation or detection of ZIKV-specific RNA. Serological diagnosis is complicated by cross-reactivity among members of theFlavivirusgenus. The adaptation of ZIKV to an urban cycle involving humans and domestic mosquito vectors in tropical areas where dengue is endemic suggests that the incidence of ZIKV infections may be underestimated. There is a high potential for ZIKV emergence in urban centers in the tropics that are infested with competent mosquito vectors such asAedes aegyptiandAedes albopictus.

show abstract

“…Transmission in this area seems to be only possible during the warm seasons. The vector is spreading to new areas, as reported in France [67,68], where a recent study confirmed the high efficiency of temperate Ae. albopictus to transmit CHIKV [69•].…”

Section: Epidemiology Of Chikv By Continentmentioning

confidence: 52%

Emergence and Surveillance of Chikungunya

et al. 2015

View full text Add to dashboard Cite

Chikungunya virus (CHIKV), an arbovirus transmitted by Aedes mosquitoes, causes a disease characterised by fever, headache, skin rash, myalgias and severe arthralgias: the latter can persist for years. Following the first report in Africa in 1952, sporadic epidemics have been registered in Africa and in Asia before 2000. Since 2005, huge outbreaks have been reported, caused by globalisation (increasing displacement of humans and mosquitoes) and by an evolutionary success related to the adaptation of CHIKV to the mosquito vector: Therefore, CHIKV spread also in Europe, Oceania and the Americas. In endemic areas, seroprevalence studies could contribute to early detection of epidemics and to have a real picture of the burden of this disease. In temperate areas where Aedes aegypti and/or Aedes albopictus are present, CHIKV control measures require surveillance of imported and autochthonous cases, rapid diagnosis to detect local outbreaks and entomological surveillance.

show abstract

Autochthonous case of dengue in France, October 2013

Abstract: Binary file ES_Abstracts_Final_ECDC.txt matches

Cited by 147 publications

References 61 publications

The Health Effects of Climate Change in the WHO European Region

The Health Effects of Climate Change in the WHO European Region

Zika Virus

Emergence and Surveillance of Chikungunya

Contact Info

Product

Resources

About